Genentech / Roche
South San Francisco, California
Genentech, a member of the Roche Group, is a pioneering biotechnology company with a major presence in oncology, immunology, and neuroscience. Their portfolio includes Ocrevus (the leading MS therapy), Rituxan (rituximab), and multiple oncology drugs. Genentech has robust patient support programs.
Drugs
Hub Program — Genentech Access Solutions
- ✓Insurance verification and benefits investigation
- ✓Prior authorization and appeals support
- ✓Copay assistance programs for commercially insured patients
- ✓Genentech Patient Foundation (free medication for eligible patients)
- ✓Infusion site coordination and nurse support
Patient Assistance
Copay Assistance
Genentech offers copay assistance for commercially insured patients across their product portfolio, including Ocrevus, Rituxan, and oncology products.
Patient Assistance Program (PAP)
Genentech Patient Foundation provides free Genentech medicines to patients who are uninsured or underinsured and meet eligibility criteria.
Denied a Genentech / Roche Drug?
Ellen can decode your denial, identify the specific reason, and generate a personalized appeal letter — free.